Gennex Lab Peer Comparison

BSE: 531739

₹10.27

₹-0.16 (-1.53%)

As on 18-Sep-2026IST

Market cap

₹250 Cr

Revenue (TTM)

₹183 Cr

P/E Ratio

12.9

P/B Ratio

1.1

Div. Yield

0 %

Edit

	Gennex Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Market cap (₹ Cr)	250	20,887	19,967	18,310	18,305
Revenue (₹ Cr)	183	2,287	1,682	3,230	2,570
Net Profit (₹ Cr)	20.63	678.07	273.51	666.92	735.15
Net Margin (%)	11.07	28.10	16.19	20.60	26.88
RoE (%)	9.14	19.73	11.15	18.75	19.16
Price to Earnings	12.87	31.39	67.16	28.44	24.90
Price-To-Book	1.10	5.69	7.43	4.54	4.15

Income Statement (₹ Cr)

	Gennex Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Operating Revenue	183.06	2,287.33	1,682.47	3,229.67	2,569.77
Total Income	186.38	2,413.29	1,689.83	3,237.12	2,735.39
Total Expenditure	156.66	1,490.75	1,203.91	2,090.06	1,628.14
EBITDA	26.39	796.58	478.55	1,139.61	941.63
Depreciation	2.71	78.10	126.01	281.06	57.58
EBIT	23.68	718.48	352.55	858.55	884.05
Interest	4.12	0.88	52.11	190.64	7.69
Other Income	3.33	125.96	7.37	7.45	165.62
Exceptional Items	-0.60	0.00	12.16	-17.24	-49.16
Profit before Tax	22.29	843.56	319.96	658.12	992.82
Provision for Tax	1.66	165.49	46.45	-8.80	257.67
Profit after Tax	20.63	678.07	273.51	666.92	735.15

	Gennex Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Shareholder's Funds	222.52	3,586.42	2,591.20	3,902.67	4,202.90
Minority Interest	-1.23	-12.71	0.00	-21.81	0.00
Non-Current Liabilities	43.44	28.74	266.35	1,392.75	91.50
Current Liabilities	72.40	385.94	848.06	2,077.10	627.48
Total Liabilities	256.04	3,207.85	3,310.68	6,865.52	4,911.11

	Gennex Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Non-Current Assets	74.07	1,291.22	2,525.44	5,617.77	770.28
Current Assets	264.66	2,585.66	1,109.77	1,539.85	3,803.22
Total Assets	256.04	3,207.85	3,310.68	6,865.52	4,911.11
Total Debt*	24.28	0.55	586.37	2,421.66	2.50
Net Current Assets	192.26	2,199.72	261.71	-537.25	3,175.74
Contingent Liabilities	0.98	0.64	76.22	51.96	363.79

	Gennex Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Cash From Operating Activities	-10.80	432.37	132.27	1,065.01	659.75
Cash Flow from Investing Activities	0.82	-334.73	-199.13	-79.97	-71.34
Cash from Financing Activities	4.57	-38.32	62.65	-881.32	-205.34
Net Cash Inflow / Outflow	-5.41	59.32	-4.21	103.72	383.07

	Gennex Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
ROCE (%)	12.49	26.22	6.95	13.59	26.21
ROE (%)	9.14	19.73	11.15	18.75	19.16
ROA (%)	6.82	18.69	7.80	9.26	14.95
EBIT Margin (%)	12.94	31.41	20.95	26.58	34.40
Net Margin (%)	11.07	28.10	16.19	20.60	26.88
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Gennex Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Revenue Growth (%)	23.78	15.01	27.91	9.59	10.69
EBIT Growth (%)	18.82	18.45	58.32	16.84	24.14
Net Profit Growth (%)	11.37	19.61	149.56	62.68	-9.09
EPS Growth (%)	6.03	17.73	-3.57	67.41	14.40
Book Value Growth (%)	9.90	23.77	30.63	10.19	17.30

	Gennex Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Price / Earnings	12.53	31.39	71.24	27.75	23.73
Price / Book Value	1.10	5.69	7.43	4.54	4.15
Dividend Yield (%)	0.00	0.29	0.06	0.00	1.87
EV/EBITDA	8.27	24.96	43.00	18.03	16.14
Market Cap (₹ Cr)	274.07	15,219.80	6,484.12	19,292.77	18,318.10

	Gennex Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debt to Equity	0.00	0.00	0.07	0.24	0.00
Short term debt to equity ratio	0.05	0.00	0.13	0.14	0.00
Current Ratio	3.66	6.70	1.31	0.74	6.06
Quick Ratio	2.91	5.59	0.88	0.53	5.31
Interest Coverage	6.41	959.59	7.14	4.45	130.11

	Gennex Lab	Caplin Point Lab	Shilpa Medicare	Eris Lifesciences	Pfizer
Debtors to sales (%)	23.79	36.10	30.84	21.07	7.07
Asset Turnover	0.61	0.63	0.48	0.45	0.52
Receivable days	37.35	110.70	118.15	54.06	29.10
Inventory Days	71.39	65.86	98.29	32.16	69.53
Payable days	53.27	105.88	128.16	140.91	76.77
Cash Conversion Cycle	55.46	70.68	88.28	-54.69	21.86

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.